DESCRIPTION |
Vancomycin-resistant Enterococcus (VRE) is a pathogen of increasing
parameter set-up is to identify a patient's current or prior history of
VRE based on laboratory reporting and the time frames that are entered to
search for the patient's status. This information can optionally be
displayed on the Isolation Report. This includes cultures positive for
prevalence and surveillance review, including specimens of stool and
rectal swabs. It is important to search for all vancomycin resistant
enterococci, whether speciated or not. It is important to be sure to list
all the places in the Microbiology Laboratory package where Enterococcus
are found, either as Enterococcus, E. (sp.), Group D-Streptococcus, E.
faecalis, E. faecium, E. durans, E. gallinarum, E. casseliflavus, etc.
importance for healthcare facilities. Enterococcus is a bacterium that
The laboratory parameter setup for the MDRO Program Tools should match the
same parameter setup for the EPI (Emerging Pathogens Initiative). If
changes are made to how Vancomycin-resistant Enterococcus is reported it
should also be changed in EPI parameter setup.
lives in the intestinal tract and in the female genital tract. Vancomycin
is an antibiotic that is often used to treat infections caused by
enterococci, and recently enterococci have become resistant to this drug.
Most VRE infections occur in the hospital.
NOTE: Adding Vancomycin-resistant Enterococcus to the MDRO Tools Lab
Parameter Setup is optional. The purpose of adding this pathogen to the
|